乳腺癌中的同源重组缺陷:基因组特征,临床含义和新辅助疗法的预测价值
Jing Huang1, Feiyang Luan1, Li Yan1
1Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Frontiers in oncology
|October 22, 2025
概括
同源复合缺陷 (HRD) 在中国乳腺癌患者中很常见,与特定突变和攻击性亚型 (如三阴性乳腺癌 (TNBC)) 有关. 虽然HRD状态无法预测整体的新辅助疗法反应,但HRD阳性TNBC患者从环素治疗方案中受益.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 同源重组缺陷 (HRD) 是乳腺癌发展的关键因素,影响治疗灵敏度.
- HRD阳性乳腺癌可能对向DNA的药物反应更好,包括新辅助治疗中的制剂.
- 标准化的人力资源发展评估及其在中国的临床影响需要进一步调查.
研究的目的:
- 用AmoyDxHRD套件评估中国乳腺癌患者的HRD状态.
- 评估基因组特征,临床特征和与HRD状态相关的新辅助疗法结果.
- 在中国队列中探索HRD,TP53突变和三阴性乳腺癌 (TNBC) 之间的关联.
主要方法:
- 利用AmoyDxHRD套件对133名中国乳腺癌患者进行HRD状态评估.
- 在HRD阳性和HRD阴性组之间比较基因组特征,临床特征和新辅助治疗结果.
- 分析了HRD状态,瘤亚型 (TNBC,Luminal A),基因突变 (TP53) 和治疗反应之间的相关性.
主要成果:
- 超过一半 (54.1%) 的患者表现出HRD阳性状态.
- 在HRD阳性患者中,TP53突变的发生频率明显高 (P=0.004).
- 阳性HRD瘤显示T阶段较高,ER/PR/AR表达较低,Ki67较高,TNBC发病率增加 (P<0.05).
- 患有HRD阳性的TNBC患者在以环素为基础的新辅助疗法 (P=0.042) 中实现了更高的病理完整响应 (pCR) 率.
结论:
- 使用基于GSS的方法检测HRD显示,中国乳腺癌患者的基因组和临床病理特征不同.
- HRD阳性状态,特别是高GSS分数,与较低的ER/PR和较高的Ki67表达相关,以及TNBC中更高的流行率.
- 虽然HRD状态没有显著影响整体新辅助疗法的疗效,但它确定了HRD阳性TNBC患者,他们受益于含有 antracycline 的疗法,支持个性化治疗策略.
相关概念视频
Homologous Recombination
62.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
62.6K
Crossing Over
6.1K
Crossing over is the exchange of genetic information between homologous chromosomes during prophase I of meiosis I. Genetic recombination gives rise to allelic diversity in the newly formed daughter cells. In humans, crossing over produces genetically distinct haploid egg and sperm cells that undergo fertilization to produce unique offspring. Before cell division starts, the germ cell’s chromosome(s) undergo duplication in the S phase of the cell cycle. As the cells enter prophase I,...
6.1K
Mismatch Repair
6.3K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.3K
Conservative Site-specific Recombination and Phase Variation
6.6K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.6K


